NAGE NIAGEN BIOSCIENCE INC
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about NIAGEN BIOSCIENCE INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 3 reports on NAGE from 3 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright lowered its target from $11.00 (set 1 Jul 2026) to $10.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Susan K Anderson | Buy | 12 Aug 2026 | Conflicting reports · excluded |
| Freedom Capital | Unnamed analyst | Buy | 6 Jul 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 6 Jul 2026 | 8.50 USD |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 4 Nov 2026 | 10.00 USD |
| Ladenburg Thalmann | Jeffrey S Cohen | Buy | 21 Jul 2026 | 11.00 USD |
| Roth Capital | Sean P Mcgowan | Buy | 27 Jul 2026 | 10.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:36 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.